War, AI, and Grid Stress: Why This Is Solar Power’s Moment
The war in Iran is solar power’s Covid moment.
Tariffs as Budget Pay-Fors: Three Revenue Options for Congress
As the Congressional Budget Office (CBO) projects a $1.9 trillion federal deficit for fiscal year 2026, Congress is under increasing pressure to identify durable budget pay-fors. In most cases, that discussion quickly narrows to three familiar choices: raise domestic taxes, cut spending, or continue borrowing more. But tariffs warrant more serious consideration.
Warnings Of China Taking Lead In Biopharma Future In Latest Senate Hearing
China holds a rapidly expanding position in the global biologics and biosimilars market, driven by heavy government support, regulatory reforms, and massive investments in biotech hubs like Shanghai and Suzhou.
CPA Submits Comments to USITC on China’s Permanent Normal Trade Relations
Revoking PNTR for China would move Chinese imports onto an average effective Column 2 tariff rate of 38.9 percent, helping rebalance trade, restore domestic production capacity, and reduce strategic dependence on an increasingly adversarial economic system.
CPA Applauds FDA Proposal to Strengthen U.S. Generic Drug Manufacturing and Supply Chain Integrity
CPA welcomes new proposals from the Food and Drug Administration (FDA) aimed at rebuilding domestic generic drug manufacturing, strengthening oversight of foreign pharmaceutical production, and improving supply chain transparency.
New CPA Report Shows Domestic Manufacturing Market Share Rebounds in 2025 as Tariffs Begin to Reshape U.S. Industry
The report finds that the CPA Domestic Market Share Index (DMSI) – which measures the share of U.S. demand served by domestic producers – rebounded in 2025 as Section 232 tariffs and other industrial policies began to reshape the competitive landscape for American industry.
Are Tariffs a Burden? CPA Senior Economist Mihir Torsekar Debates The Tax Foundation at Ohio State University
If there is one Washington, D.C.-based organization that is outspoken against the positions of CPA, it’s the Tax Foundation. They have been instrumental in getting many legislators to believe tariffs would be a “tax” upwards of $1,000 per household.
CPA Applauds Suniva’s Major U.S. Solar Cell Manufacturing Investment
Suniva’s expansion highlights the critical importance of rebuilding the domestic crystalline silicon photovoltaic (PV) supply chain—particularly solar cell manufacturing, one of the most strategically important segments of U.S. energy production.
Domestic Market Share Rebounds in 2025 as Sec. 232 Tariffs Begin to Reshape U.S. Manufacturing
The CPA Domestic Market Share Index (DMSI) has rebounded sharply in 2025, signaling that U.S. tariffs are beginning to restore domestic production’s share of the American market.
CPA Applauds Whirlpool Corporation’s Major Ohio Investment as Proof U.S. Trade Policy Is Driving Domestic Manufacturing Growth
The investment is clear evidence that U.S. trade policy is driving a resurgence in domestic production and job creation. This new investment underscores Whirlpool Corp.’s long-standing commitment to the U.S. market and creating high-quality American jobs.
